Medpace News

Medpace Hldgs Analyst Ratings

BenzingaApr 24 13:41 ET

Medpace Hldgs Analyst Ratings

BenzingaApr 23 11:06 ET

Medpace Hldgs Analyst Ratings

BenzingaMar 18 08:15 ET

Medpace Hldgs Analyst Ratings

BenzingaMar 8 12:07 ET

Medpace Hldgs Analyst Ratings

BenzingaFeb 14 14:03 ET

Medpace Hldgs Analyst Ratings

BenzingaJan 17 14:30 ET

UBS Adjusts Medpace Price Target to $282 From $270, Maintains Neutral Rating

MT NewswiresOct 25, 2023 11:31 ET

Medpace Holdings (NASDAQ:MEDP) Explodes Upward After Earnings, Analyst Weigh-In

TipRanksOct 24, 2023 12:02 ET

Baird Upgrades Medpace Hldgs to Outperform, Raises Price Target to $289

BenzingaOct 24, 2023 06:17 ET

Medpace Hldgs Analyst Ratings

BenzingaOct 24, 2023 06:15 ET

Analysts Conflicted on These Healthcare Names: Medpace Holdings (MEDP) and Silk Road Medical (SILK)

TipRanksOct 24, 2023 04:40 ET

UBS Adjusts Medpace Price Target to $270 From $215, Maintains Neutral Rating

MT NewswiresJul 26, 2023 11:38 ET

Guggenheim Raises Medpace Holdings' Price Target to $273 From $252, Keeps Buy Rating

MT NewswiresJul 25, 2023 10:41 ET

Guggenheim Maintains Buy on Medpace Hldgs, Raises Price Target to $273

BenzingaJul 25, 2023 08:45 ET

Medpace Hldgs Analyst Ratings

BenzingaJul 25, 2023 08:45 ET

Guggenheim Upgrades Medpace Hldgs to Buy, Announces $252 Price Target

BenzingaMay 8, 2023 09:37 ET

UBS Lowers Price Target on Medpace to $215 From $238, Keeps Neutral Rating

MT NewswiresApr 10, 2023 10:33 ET

Medpace Hldgs Analyst Ratings

Benzinga Analyst RatingsFeb 15, 2023 07:35 ET

Baird Maintains Neutral on Medpace Hldgs, Raises Price Target to $233

Benzinga Real-time NewsFeb 15, 2023 07:35 ET

UBS Upgrades Medpace Holdings to Neutral From Sell, Adjusts Price Target to $238 From $142

MT NewswiresOct 27, 2022 11:15 ET